跳至主要内容
临床试验/ACTRN12608000053325
ACTRN12608000053325招募中3 期

A multi-centre, randomised controlled trial of the effect of early goal-directed therapy, compared to standard care, on 90-day mortality in patients presenting to the Emergency Department with severe sepsis in Australasia

Australian and New Zealand Intensive Care Research Centre0 个研究点目标入组 1,600 人开始时间: 2008年1月29日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
1,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 /A(—)
性别
All

入选标准

  • 1. Suspected or confirmed infection
  • 2. 2 or more systemic inflammatory response syndrome (SIRS) criteria
  • 3. Evidence of either refractory hypertension or hypoperfusion

排除标准

  • Contra-indication to superior vena cava central venous catheter insertion; contra-indication to blood products; inability to commence delivery of EGDT protocol within 1 hour of randomisation or complete 6 hours of EGDT; haemodynamic instability due to active bleeding; pregnancy; transfer from another ED or acute health care facility; the patient has an underlying disease process with a life expectancy of < 90 days; death is deemed imminent and inevitable; a limitation of therapy order has been documented

研究者

相似试验

Australasian Resuscitation In Sepsis Evaluation... | 临床试验